Isolated hepatic perfusion with tumor necrosis factor alpha and melphalan: experimental studies in pigs and phase I data from humans.

Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer

Volumn 147, Issue , 1998, Pages 107-119

  de Vries, M R ^a   Borel Rinkes, I H ^a   van de Velde, C J ^a   Wiggers, T ^a   Tollenaar, R A ^a   Kuppen, P J ^a   Vahrmeijer, A L ^a   Eggermont, A M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; ALKYLATING AGENT; INTERLEUKIN DERIVATIVE; MELPHALAN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL; ARTICLE; BLOOD CLOTTING; CLINICAL TRIAL; COLORECTAL TUMOR; DRUG EFFECT; HUMAN; LIVER TUMOR; METABOLISM; METASTASIS; MORTALITY; PATHOLOGY; PERFUSION; PHASE 1 CLINICAL TRIAL; SOLUBILITY; SURVIVAL RATE; SWINE; TREATMENT OUTCOME;

ACUTE-PHASE PROTEINS; ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; BLOOD COAGULATION; COLORECTAL NEOPLASMS; HUMANS; INTERLEUKINS; LIVER NEOPLASMS; MELPHALAN; PERFUSION; RECEPTORS, TUMOR NECROSIS FACTOR; SOLUBILITY; SURVIVAL RATE; SWINE; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

MLCS; MLOWN;

EID: 0031637434     PISSN: 00800015     EISSN: None     Source Type: Journal    
DOI: 10.1007/978-3-642-80460-1_11     Document Type: Article

References (0)